Operational Performance Highlights

  • Bed Capacity: 4,290 beds across 17 hospitals as of November 13, 2026
  • New Facilities: The Medicity, Rudrapur (330 beds) operational since August 2026
  • Patient Volume: Treated more than half a million patients in H1 FY27
  • ICU Capacity: 1,166 ICU beds across the network
  • Geographic Presence: 15 cities across 6 states in North India
  • Accreditations: 17 NABH accredited hospitals, 9 NABL accredited labs (with 4 additional labs planned for NABL accreditation)

Financial Performance - Q2 FY27

  • Revenue: ₹5,110 million, up 25% YoY from ₹4,102 million in Q2 FY26
  • Cost of Materials: ₹1,163 million, increased 65% YoY
  • Employee Costs: ₹1,002 million, increased 30% YoY
  • Professional Fees: ₹702 million, increased 17% YoY
  • Other Expenses: ₹1,225 million, increased 37% YoY
  • EBITDA: ₹1,017 million, decreased 10% YoY from ₹1,127 million
  • EBITDA Margin: 20%, declined 758 bps from 27% in Q2 FY26
  • Other Income: ₹96 million, increased 20% YoY
  • Finance Costs: ₹141 million, decreased 3% YoY
  • Depreciation: ₹209 million, increased 40% YoY
  • PBT: ₹764 million, decreased 16% YoY from ₹913 million
  • Tax: ₹220 million, increased 74% YoY
  • Net Profit: ₹545 million, decreased 31% YoY from ₹787 million
  • Net Profit Margin: 11%, declined 853 bps from 19%
  • EPS: ₹1.26, decreased 38% YoY from ₹2.05

Financial Performance - H1 FY27

  • Revenue: ₹9,867 million, up 22% YoY from ₹8,090 million in H1 FY26
  • Cost of Materials: ₹1,926 million, increased 37% YoY
  • Employee Costs: ₹1,926 million, increased 25% YoY
  • Professional Fees: ₹1,458 million, increased 21% YoY
  • Other Expenses: ₹2,279 million, increased 29% YoY
  • EBITDA: ₹2,278 million, increased 5% YoY from ₹2,177 million
  • EBITDA Margin: 23%, declined 382 bps from 27% in H1 FY26
  • Other Income: ₹173 million, increased 16% YoY
  • Finance Costs: ₹239 million, decreased 20% YoY
  • Depreciation: ₹397 million, increased 34% YoY
  • PBT: ₹1,815 million, increased 5% YoY from ₹1,732 million
  • Tax: ₹384 million, increased 33% YoY
  • Net Profit: ₹1,431 million, decreased 1% YoY from ₹1,442 million
  • Net Profit Margin: 14%, declined 333 bps from 18%
  • EPS: ₹3.31, decreased 12% YoY from ₹3.75

Balance Sheet Position (H1 FY27)

  • Net Worth: ₹22,851 million (vs ₹21,043 million in FY26)
  • Reserves: ₹20,728 million (vs ₹19,356 million in FY26)
  • Non-Current Borrowings: ₹1,779 million (vs ₹190 million in FY26)
  • Current Borrowings: ₹2,792 million (vs ₹2,089 million in FY26)
  • Cash & Bank Balance: ₹2,715 million (vs ₹4,314 million in FY26)
  • Fixed Assets: ₹10,987 million (vs ₹7,878 million in FY26)
  • Goodwill: ₹4,247 million (vs ₹3,899 million in FY26)
  • Trade Receivables: ₹8,710 million (vs ₹5,935 million in FY26)
  • Total Assets: ₹32,111 million (vs ₹28,131 million in FY26)

Growth Strategy and Expansion Plans

  • FY27 Capacity Addition: 1,430 beds (40% over FY26 closing capacity)
  • Upcoming Facilities: Febris (Delhi), Palam Vihar expansion (Gurugram), Mehar Hospital (Zirakpur), Kanpur facility
  • Target Capacity: 6,590 beds by December 2028 (83% growth from March 2026)
  • Expansion Model: Mix of greenfield projects and acquisitions
  • Funding Strategy: Internal accruals and debt, with equity optionality (promoter holding at 82.9% with headroom for dilution)

Management Commentary

Dr. Ankit Gupta, Managing Director, stated that H1 FY27 was a period of record growth and significant investment. He noted that onboarding new capacity has had a near-term bearing on occupancy and profitability as new facilities take time to ramp up. The priorities are seamless integration of new assets, improving utilization and margins.

Revenue Streams and Payor Mix

  • Primary Revenue Drivers: In-patient services (surgeries, critical care, ICU treatments across 30+ specialties)
  • Secondary Revenue: Out-patient services (consultations, diagnostics, minor procedures)
  • Ancillary Services: In-house pharmacy, diagnostics, radiology & lab services
  • Government Schemes: Empanelled under ESIC, CGHS, ECHS and Ayushman Bharat (PMJAY)
  • Insurance: TPA-linked cashless and direct insurance billing
  • Self-Pay Patients: Cash-pay middle & lower-middle income segment

Management Team

  • Dr. Ajit Gupta: Promoter, Chairman and Whole Time Director (44 years medical experience)
  • Dr. Ankit Gupta: Promoter and Managing Director (20+ years medical experience)
  • Senior Management: Experienced team including Group Medical Director, CFO, COO, Chief Strategy Officer, and Company Secretary

Website and Contact Information

The disclosure is available on the Company's website at https://www.parkhospital.in/. Investor relations contact: investor.relations@parkhospital.in